Andreas G. Schatzlein

Citée par

	Toutes	Depuis 2020
Citations	9535	2223
indice h	43	25
indice i10	69	51

580

290

145

435

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202530 28 61 74 112 181 186 258 327 316 400 397 446 417 571 508 524 528 569 494 436 365 427 471 446 428 389 59

Accès public

Tout afficher

26 articles

2 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Christine DufèsReader, University of StrathclydeAdresse e-mail validée de strath.ac.uk
Dr. Gabriele BlumeOwner of SopharcosAdresse e-mail validée de sopharcos.de
Aikaterini LalatsaReader in Nanomedicines, University of StrathclydeAdresse e-mail validée de strath.ac.uk
Prof. Julian MogerUniversity of ExeterAdresse e-mail validée de ex.ac.uk
Natalie GarrettScientific Manager, Met OfficeAdresse e-mail validée de metoffice.gov.uk
Maria de la FuenteIDIS, Institute of Health Research of Santiago de Compostela (IDIS), Santiago de Compostela, SpainAdresse e-mail validée de sergas.es
Kim AppletonAdresse e-mail validée de beatson.gla.ac.uk
M. J. Santander-OrtegaUniversity of Castilla La-ManchaAdresse e-mail validée de uclm.es
Mazen El-HammadiUniversity of Seville, and Damascus UniversityAdresse e-mail validée de us.es
Bernd H. ZinselmeyerWashington University in St Louis - Associate Professor at the Department of PathologyAdresse e-mail validée de wustl.edu
David George WatsonStrathclydeAdresse e-mail validée de strath.ac.uk
JUAN JOSE TORRADO DURANUniversidad Complutense de MadridAdresse e-mail validée de ucm.es
Vitaliy KhutoryanskiyProfessor of Formulation Science, University of ReadingAdresse e-mail validée de reading.ac.uk
Stephen NeidleEmeritus Professor of Chemical Biology, The UCL School of Pharmacy, University of LondonAdresse e-mail validée de ucl.ac.uk
Ian R SummersRetired, University of ExeterAdresse e-mail validée de exeter.ac.uk
Federico BrucoliLecturer in Medicinal Chemistry, Leicester School of Pharmacy, De Montfort UniversityAdresse e-mail validée de uws.ac.uk
Tamara KingUniversity of New EnglandAdresse e-mail validée de une.edu
Abbas PardakhtyProfessor of Pharmaceuitcs, Pharmaceutics Research Center, Neuropharmacology Institute, KermanAdresse e-mail validée de kmu.ac.ir
Ronit Satchi-FainaroProfessor, Tel Aviv UniversityAdresse e-mail validée de post.tau.ac.il
Simon GaisfordUCLAdresse e-mail validée de ucl.ac.uk

Suivre

Andreas G. Schatzlein

UCL School of Pharmacy

Adresse e-mail validée de ucl.ac.uk


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Dendrimers in gene delivery C Dufès, IF Uchegbu, AG Schätzlein Advanced drug delivery reviews 57 (15), 2177-2202, 2005	1292	2005
Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin G Cevc, D Gebauer, J Stieber, A Schätzlein, G Blume Biochimica et Biophysica Acta (BBA)-Biomembranes 1368 (2), 201-215, 1998	715	1998
Gene delivery with synthetic (non viral) carriers MD Brown, AG Schätzlein, IF Uchegbu International Journal of Pharmaceutics 229 (1-2), 1-21, 2001	588	2001
Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides G Cevc, A Schätzlein, G Blume Journal of Controlled Release 36 (1-2), 3-16, 1995	547	1995
Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements G Cevc, A Schätzlein, H Richardsen Biochimica et Biophysica Acta (BBA)-Biomembranes 1564 (1), 21-30, 2002	463	2002
The skin: a pathway for systemic treatment with patches and lipid-based agent carriers G Cevc, G Blume, A Schätzlein, D Gebauer, A Paul Advanced drug delivery reviews 18 (3), 349-378, 1996	349	1996
Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo G Cevc, G Blume, A Schätzlein Journal of controlled release 45 (3), 211-226, 1997	297	1997
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors K Appleton, HJ Mackay, I Judson, JA Plumb, C McCormick, G Strathdee, ... Journal of Clinical Oncology 25 (29), 4603-4609, 2007	266	2007
Amphiphilic poly (l-amino acids)—new materials for drug delivery A Lalatsa, AG Schätzlein, M Mazza, TBH Le, IF Uchegbu Journal of Controlled Release 161 (2), 523-536, 2012	263	2012
Non‐uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high‐resolution confocal laser scanning microscopy study using highly … A Schätzlein, G Cevc British Journal of Dermatology 138 (4), 583-592, 1998	249	1998
Tumour vasculature as a target for anticancer therapy MM Eatock, A Schätzlein, SB Kaye Cancer treatment reviews 26 (3), 191-204, 2000	235	2000
Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents MD Brown, A Schätzlein, A Brownlie, V Jack, W Wang, L Tetley, AI Gray, ... Bioconjugate chemistry 11 (6), 880-891, 2000	223	2000
Polymeric chitosan-based vesicles for drug delivery IF Uchegbu, AG Schätzlein, L Tetley, AI Gray, J Sludden, S Siddique, ... Journal of pharmacy and pharmacology 50 (5), 453-458, 1998	209	1998
Nose-to-brain delivery Z Wang, G Xiong, WC Tsang, AG Schätzlein, IF Uchegbu Journal of Pharmacology and Experimental Therapeutics 370 (3), 593-601, 2019	204	2019
Polymers in drug delivery IF Uchegbu, AG Schatzlein CRC Press, 2006	201	2006
Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude X Qu, VV Khutoryanskiy, A Stewart, S Rahman, ... Biomacromolecules 7 (12), 3452-3459, 2006	186	2006
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors C Dufes, WN Keith, A Bilsland, I Proutski, IF Uchegbu, AG Schätzlein Cancer research 65 (18), 8079-8084, 2005	176	2005
PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility A Brownlie, IF Uchegbu, AG Schätzlein International journal of pharmaceutics 274 (1-2), 41-52, 2004	174	2004
Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles C Dufes, JM Muller, W Couet, JC Olivier, IF Uchegbu, AG Schätzlein Pharmaceutical research 21, 101-107, 2004	161	2004
Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting C Dufes, AG Schätzlein, L Tetley, AI Gray, DG Watson, JC Olivier, ... Pharmaceutical research 17, 1250-1258, 2000	151	2000

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs